Takafumi Koyauchi
Hamamatsu, 4338558, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Primary Malignant Melanoma of the Lung.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2025
Primary Malignant Melanoma of the Lung.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2025
Psychological palliative care for patients with interstitial lung disease in Japan: A secondary analysis of a National Survey of Japanese Respiratory Physicians.
Journal: Respiratory investigation
Published: August 25, 2025
Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey.
Journal: Annals of the American Thoracic Society
Published: November 08, 2024
Non-tuberculosis Mycobacterial Pulmonary Disease Caused by Mycobacterium kiyosense, a New Species.
Journal: Internal medicine (Tokyo, Japan)
Published: November 12, 2023
Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists.
Journal: Respirology (Carlton, Vic.)
Published: October 10, 2022
Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Journal: Respiratory investigation
Published: June 26, 2022
Chromatin-remodeling factor BAZ1A/ACF1 targets UV damage sites in an MLL1-dependent manner to facilitate nucleotide excision repair.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 03, 2022
End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation.
Journal: Respiratory research
Published: January 06, 2022
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Journal: Respiratory research
Published: September 07, 2021
Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Journal: Therapeutic advances in respiratory disease
Published: February 13, 2020
Last Updated: 09/26/2026